PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-10-02

Date Title Company
02-Oct-2025 Continuity of Care for Rural Pharmacies ACCESS Newswire
02-Oct-2025 Enanta Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Businesswire
02-Oct-2025 Drafting Commercial Contracts for the Pharmaceutical Industry Training Course: Explore IP Issues, Competition Regulations, Licensing and Collaboration Strategies (Nov 12th-13th, 2025) - ResearchAndMarkets.com Businesswire
02-Oct-2025 In Powerful Partnership Focused on Customers, Ribbon Bio and Scala Biodesign Advance Enzyme Innovation with Next-Generation Technologies Businesswire
02-Oct-2025 Navitas Life Sciences Named a Major Contender in Everest Group Clinical Data Management Operations PEAK Matrix(R) Assessment 2025 Newswire
02-Oct-2025 EGFR Inhibitors Induced Skin Disorders Market Research 2025-2035: Epidemiology, Regulations, Pipeline Analysis Featuring Azitra, Hoth Therapeutics, and Lutris Pharma - ResearchAndMarkets.com Businesswire
02-Oct-2025 UniDoc Announces LIFE Offering ACCESS Newswire
02-Oct-2025 Trinity Life Sciences Accelerates Future with Strategic Brand Transformation and AI-Enabled Solutions Businesswire
02-Oct-2025 Artificial Intelligence In Pharmaceutical Industry Research Report 2025: Market to Explode and Reach a Value of Over $65 Billion by 2033, from $3.24 Billion in 2024 - ResearchAndMarkets.com Businesswire
02-Oct-2025 Immunis Honored with the National Academy of Medicine’s 2025 Healthy Longevity Catalyst Award Businesswire
02-Oct-2025 EU and USA Understanding Active Pharmaceutical Ingredients (APIs) Training Course: Learn GMP Compliance, Small vs. Large Molecule Processing and Supply Chain Risk Management (Online: Nov 19, 2025) - ResearchAndMarkets.com Businesswire
02-Oct-2025 Allergy Treatment Global Market Forecast and Company Analysis Report 2025-2033 Featuring AbbVie, ALK-Abello, ALLERGOPHARMA, Almirall, DBV, GSK, HAL Allergy, Novartis, Teva, and Viatris - ResearchAndMarkets.com Businesswire
02-Oct-2025 Leica Biosystems Expands Leading Digital Pathology Portfolio for the US with Multiple Launches at Pathology Visions 2025 Leica Biosystems
02-Oct-2025 Asabys Partners Integrates Aliath Bioventures Life Sciences Investment Platform in Strategic Move with AltamarCAM Asabys Partners
02-Oct-2025 Neuraxpharm strengthens multiple sclerosis portfolio with the launch of Riulvy® (tegomil fumarate) Neuraxpharm
02-Oct-2025 Hormone Sensitive Advanced Prostate Cancer Market Analysis Report 2025-2035: Overview and Ecosystem, Epidemiological Analysis, Key Trends, Regulatory Landscape, Pipeline Analysis - ResearchAndMarkets.com Businesswire
02-Oct-2025 n-Lorem Foundation Organizes Third Annual Nano-rare Patient Colloquium, Highlighting Scientific and Clinical Advancements Achieved Since Organization’s Founding Businesswire
02-Oct-2025 Virtual How to Interview During GMP (Good Manufacturing Practice) Audits Training Course: Learn Techniques, Critical Thinking, Compliance Insights and Soft Skills for Effective Auditing (Nov 10, 2025) - ResearchAndMarkets.com Businesswire
02-Oct-2025 Positive Persuading and Influencing Skills for Pharma Professionals Workshop: Persuade Stakeholders Across the US, Canada, UK and EMEA (Nov 10th - Nov 13th, 2025) - ResearchAndMarkets.com Businesswire
02-Oct-2025 Neuraptive Therapeutics, Inc. Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating the Safety and Efficacy of NTX-001 Compared to Standard of Care in the Treatment of Upper Extremity Transected Nerves Requiring Surgical Repair Businesswire